EKR Therapeutics
Bedminster
About EKR Therapeutics
EKR Therapeutics, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea. The company was founded in 2005 and is based in Bedminster, New Jersey.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $163.0M
- Funding stage: M&A
- Last round: Series D (Mar 2008)
- Website: ekrtx.com
- Phone: 9786831799
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ekr-therapeutics-2633788 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.